Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Shares Outstanding (Diluted Average) (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $58.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 1.17% to $58.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.5 million through Dec 2025, up 1.17% year-over-year, with the annual reading at $58.5 million for FY2025, 1.17% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $58.5 million in Q4 2025 for Harmony Biosciences Holdings, roughly flat from $58.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $61.2 million in Q1 2023 to a low of $57.5 million in Q2 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $59.3 million across 5 years, with a median of $58.8 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 654.82% in 2021 and later fell 5.92% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $59.2 million in 2021, then grew by 3.2% to $61.1 million in 2022, then dropped by 1.19% to $60.4 million in 2023, then dropped by 4.15% to $57.9 million in 2024, then increased by 1.17% to $58.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for HRMY at $58.5 million in Q4 2025, $58.7 million in Q3 2025, and $58.5 million in Q2 2025.